Effect of p53 haploinsufficiency on melphalan-induced genotoxic effects in mouse bone marrow and peripheral blood

R Ranaldi1, S Palma, C Tanzarella

  • 1Section of Toxicology and Biomedical Sciences, ENEA, CR Casaccia, Via Anguillarese 301, 00060 Roma, Italy.

Mutation Research
|November 18, 2006
PubMed

Insights

Mice with one functional p53 gene (p53+/-) showed weak, temporary differences in DNA damage response compared to normal mice (p53+/+) after melphalan exposure. This suggests p53 haploinsufficiency has a limited impact on genotoxicity testing models.

Area of Science:

  • Toxicology and Carcinogenesis
  • Genetics and Molecular Biology
  • Animal Models in Research

Background:

  • Mice heterozygous for a p53 null mutation (p53+/-) are proposed as an alternative model for carcinogenicity testing due to shorter tumor latency.
  • Literature suggests p53+/- mice may exhibit increased sensitivity to genotoxic agents and a haploinsufficiency phenotype contributing to tumor susceptibility.

Purpose of the Study:

  • To compare the induction of micronuclei in p53+/- and p53+/+ mice after melphalan (MLP) treatment.
  • To characterize the mechanism of MLP-induced micronucleus formation (chromosome break vs. loss).
  • To investigate evidence of p53 haploinsufficiency in cell cycle modulation and apoptotic pathways.

Main Methods:

  • Treatment of isogenic p53+/- and p53+/+ mice with single or multiple doses of melphalan (MLP).
  • Analysis of micronuclei induction in bone marrow polychromatic erythrocytes and peripheral blood reticulocytes.
  • CREST staining of kinetochore proteins to differentiate between chromosome break and loss events.
  • Assessment of cytotoxicity and cell cycle delay via polychromatic erythrocyte frequency.

Main Results:

  • MLP induced significant increases in micronucleated cells in both mouse genotypes under all exposure conditions.
  • Micronuclei were primarily a result of chromosome breaks.
  • p53+/+ mice showed cytotoxicity/cell cycle delay after a single MLP dose, an effect absent in p53+/- mice, suggesting p53 haploinsufficiency.
  • No statistically significant differences in micronuclei frequency were observed between p53+/- and p53+/+ mice, indicating weak and temporary effects of p53 haploinsufficiency.

Conclusions:

  • p53 haploinsufficiency in p53+/- mice appears to have weak and temporary effects on cell cycle modulation and DNA damage response to melphalan.
  • The increased susceptibility of p53+/- mice to MLP-induced tumors cannot be solely attributed to a higher or faster induction of irreversible chromosome damage.
  • Further research is needed to fully elucidate the role of p53 haploinsufficiency in carcinogenicity testing models.